- 1、本文档共84页,可阅读全部内容。
- 2、有哪些信誉好的足球投注网站(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
支气管哮喘诊治进展整理ppt
哮喘的诊断 支气管哮喘的分期 急性发作期 慢性持续期 临床缓解期 哮喘的诊断 哮喘的分级 病情严重程度分级 控制水平的分级 急性发作期严重程度分级 哮喘的诊断 分期与分级是哮喘诊断的重要内容 完整的诊断应包括: 1. 疾病的诊断:如支气管哮喘 2. 分期:如急性发作期(重度) 3. 分级:如未控制 * 2 Asthma diagnosis depends both on the results of lung function tests and symptom assessment. Neither symptoms nor lung function tests alone are sufficient to form a diagnosis. * Figure 2-5. Levels of Asthma Control Characteristic:Controlled Partly controlled(Any measure present in any week) Uncontrolled Daytime symptoms:None (or minimal) Twice or more/week Three or more present in any week Limitations oactivities:None Any Three or more present in any week Nocturnal symptoms/awakening:None Any Three or more present in any week Need for rescue/”reliever” treatment:None (or minimal) Twice or more/week Three or more present in any week Lung function (PEF or FEV1):Normal or near-normal 80% predicted or personal best (if known) Three or more present in any week Exacerbations:Minimal One or more/year One in any week * In treatment-na?ve patients with persistent asthma, treatment should be start at Step 2, or, if very symptomatic (uncontrolled), at step 3. All patients with persistent asthma require one or more regular controller medications (Steps 2 through 5). Step 2 is the initial treatment for most treatment-na?ve patients with persistent asthma symptoms. If symptoms at the initial consultation suggest that asthma is poorly controlled, initial treatment may be commenced at step 3. The scheme presented in Figure is based upon these principles, but the range and sequence of medications used in each clinical setting will vary depending on local availability (for cost or other reasons), acceptability and preference. * The Gaining Optimal Asthma controL (GOAL) study grew out of the analysis of the first clinical data available with Seretide, which formed part of the registration package. The Steering Committee of internationally recognise
文档评论(0)